nav-left cat-right
cat-right

Validated biomarkers will drive personalized medic...

Biomarkers will be accepted as predicted tools, but their clinical usefulness needs to be understood first, according to personalized medicine expert. Coordinating personalized medicine on an international level, Dr Edward Abrahams, Executive Director of the Personalized Medicine Coalition believes that biomarkers will eventually impact all disease areas. “When they were validated, and when it can be understood how...

Health Care’s Silent Spring

As the Intergovernmental Working Group (IGWG) of the WHO prepares to meet and discuss how to best facilitate the expropriation of intellectual property rights (in this case the IPR of pharmaceutical patents) it’s important to consider the unintended consequences — the death of medical innovation. The global purloiners of patents — led by Jamie Love — are thrilled to point out all of the new and...

ViroStatics Establishes Scientific Advisory Board ...

SASSARI, Italy & PRINCETON, N.J. – (Business Wire) ViroStatics, srl, a privately-held pharmaceutical company focused on the discovery and development of combination therapeutics in HIV/AIDS, virology, and other chronic diseases, today announced the formation of a Scientific Advisory Board (SAB). Chaired by Daniel Kuritzkes, MD, Director of AIDS Research, Brigham & Women’s Hospital in Boston, the...

SRI helps develop screening program for AIDS drugs

Research conducted at Birmingham’s Southern Research Institute helped develop a system to identify drugs with the ability to fight the virus that causes AIDS. Trana Discovery, a North Carolina-based drug discovery technology company, worked with Southern Research to create a screening system to identify drugs that inhibit HIV replication. The system can be used by pharmaceutical companies to “rapidly and...

Quest for a cure

In Quest for a Cure, Peter Day reports on whether the US Food and Drug Administration will licence the HIV/AIDS drug Maraviroc. Maraviroc, a new HIV/AIDS drug was developed by Pfizer – the world’s largest pharmaceutical company – at its vast research and development center located at Sandwich in Kent, on the southeastern tip of England. In the first two episodes (broadcast last year), the series examined...

AIDS researchers find protein that greatly boosts ...

German AIDS researchers have discovered a protein common in semen that boosts the infectious potential of HIV 100,000-fold – a remarkable finding that may show how the virus can spread through sexual contact and also suggests new strategies to stop the epidemic. If scientists can find a drug or chemical that blocks these infection-promoting proteins, it would go a long way toward development of a microbicide, a vaginal...
Page 5 of 7« First...34567